Histone cluster 1 H3B Activators
Histone cluster 1 H3B Activators are a set of chemical compounds that enhance the functional activity of Histone cluster 1 H3B through various mechanisms related to chromatin modification and transcription regulation. TrichostHistone cluster 1 H3B Activators encompass a collection of chemical entities that facilitate the transcriptional activity of Histone cluster 1 H3B by modulating chromatin dynamics and histone modifications. Trichostatin A, Sodium butyrate, SAHA (Vorinostat), and M344, all function as histone deacetylase inhibitors, thereby increasing acetylation of Histone cluster 1 H3B and other histones. This hyperacetylation leads to a more relaxed chromatin state, enhancing the transcriptional potential where Histone cluster 1 H3B is involved. Moreover, 5-Azacytidine, RG108, and (-)-Epigallocatechin-3-gallate (EGCG) exert their activating effects by inhibiting DNA methylation. The consequent hypomethylation of DNA strands promotes a transcription-friendly environment, which can amplify the role of Histone cluster 1 H3B in gene expression. BIX-01294 and SGC0946, by selectively inhibiting histone methyltransferases targeting H3K9 and DOT1L respectively, diminish repressive methylation marks, indirectly contributing to the activation of Histone cluster 1 H3B-associated genes. These modifications collectively result in an epigenetic landscape that favors transcriptional activation, thereby enhancing the functional role of Histone cluster 1 H3B in regulating gene expression.
In addition to the aforementioned modifiers of histone acetylation and methylation, other compounds like Parthenolide, MS-275 (Entinostat), and PFI-1 contribute to the activation of Histone cluster 1 H3B through distinct yet complementary pathways. Parthenolide's inhibition of NF-κB can relieve repression of certain genes, indirectly augmenting Histone cluster 1 H3B's functional activity by fostering a transcriptionally permissive state. MS-275, similar to other HDAC inhibitors, specifically increases the acetylation levels of histones, including Histone cluster 1 H3B, thereby enhancing transcriptional activation. PFI-1 interrupts the recognition of acetylated lysine residues on histones by BET bromodomains, which may sustain a transcriptionally active state and further elevate the functional activity of Histone cluster 1 H3B. These activators, through a concerted modulation of transcription-related processes, amplify the role of Histone cluster 1 H3B in the dynamic regulation of chromatin structure and gene expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that promotes acetylation of histones, including Histone cluster 1 H3B. Enhanced acetylation of HIST1H3B leads to a more open chromatin state, facilitating increased transcriptional activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate acts as a histone deacetylase inhibitor, leading to the accumulation of acetylated Histone cluster 1 H3B. This alteration enhances transcriptional activation associated with acetylated chromatin. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, or SAHA, inhibits histone deacetylases, leading to hyperacetylation of Histone cluster 1 H3B. This results in a relaxed chromatin structure, allowing for increased transcription of genes associated with HIST1H3B. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 is a BET bromodomain inhibitor that prevents BRD4 from binding to acetylated histones, including Histone cluster 1 H3B. This can lead to enhanced transcription from chromatin regions where HIST1H3B is present. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
BIX-01294 is a G9a histone methyltransferase inhibitor, which can lead to decreased methylation of H3K9 near the HIST1H3B gene, potentially facilitating the activation of HIST1H3B-associated gene expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 is a DNA methyltransferase inhibitor. By reducing DNA methylation, it can indirectly lead to the increased expression of genes, including those involving Histone cluster 1 H3B, by promoting a more transcriptionally permissive state. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2'-deoxycytidine inhibits DNA methyltransferases, which can result in reduced methylation of DNA and associated histones, including Histone cluster 1 H3B, ultimately leading to enhanced gene expression. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
MS-275 is a selective HDAC inhibitor that increases acetylation levels of histones, such as Histone cluster 1 H3B, leading to an open chromatin structure and enhanced gene transcription. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Anacardic Acid inhibits histone acetyltransferase (HAT) enzymes, which can lead to increased acetylation of Histone cluster 1 H3B when HAT inhibition is selective, enhancing the transcription of associated genes. | ||||||
I-CBP112 | 1640282-31-0 | sc-507494 | 25 mg | $400.00 | ||
I-CBP112 is a selective CBP/p300 bromodomain inhibitor, which can increase the acetylation levels of Histone cluster 1 H3B by preventing the reading of acetylation marks, promoting an open chromatin state and active transcription. | ||||||